Navigation Links
Gene flux can foretell survival for trauma patients, Princeton study finds
Date:9/13/2011

five graphs of gene expression patterns to establish the patient's overall risk of infection and death.

"We wanted something a doctor could use in the clinical setting to ascertain a patient's condition," Storey said. "The way to do that was through a model that is incredibly simple and a straightforward depiction of natural processes.

"With the amount of data we started with, we struggled for years before we realized that this type of model was the way to go," Storey said. "It wasn't obvious, and our inclination was to produce a complicated model of all gene expression. It was similar to using simple tools to fix a car when the temptation is to rebuild the engine. But the simple tools worked very well."

That simple tool -- a practical clinical model fashioned from reams of expression data -- is a significant step toward using genomic analyses to directly treat patients, said Stephen Friend, president of Seattle-based Sage Bionetworks, as well as a biochemist and physician. Friend, whose company supports and assists with genomic research with clinical applications, had no role in the Princeton research, but he is familiar with it.

In the past five years, genomic profiles of patients have become commonplace in commercial and academic clinical trials, Friend said. When it comes to treatment, however, the application of genomics is not as widespread. One reason is that the advantage of monitoring a patient's gene expression -- namely that thousands of health markers can be identified through genetic activity -- also results in a problematically large dataset, as the Princeton researchers encountered.

"Their work shows a logical way to tame those tens of thousands of variables and put them in a practical, insightful guide that a clinician can use," Friend said.

"What's more important is that the Storey group applied genomics to an area that really needs it. They ordered patterns of expression in an elegant way that
'/>"/>

Contact: Morgan Kelly
mgnkelly@princeton.edu
609-258-5729
Princeton University
Source:Eurekalert  

Page: 1 2 3 4 5 6 7

Related biology news :

1. Foretelling a major meltdown
2. Termites foretell climate change in Africas savannas
3. Second lumpectomy for breast cancer reduces survival rates
4. U of MN study shows link between gene variations and cancer survival
5. Similar survival rates for Pacific salmon in Fraser, Columbia Rivers raises new questions
6. Research challenges conventional notions about salmon survival
7. Salmon smolt survival similar in Columbia and Fraser rivers
8. Shared survival mechanism explains why good nerve cells last and bad cancer cells flourish
9. Survival in a Changing World: The Journal of Experimental Biology 2009 symposium
10. From seed to nuts: human ancestors face evolved to eat survival foods
11. Genetic adaptations key to microbes survival in challenging environment
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Gene flux can foretell survival for trauma patients, Princeton study finds
(Date:1/22/2015)... 13, 2015 Technology Showcase, Hall E -   EyeLock ... today announced it will showcase its EyeLock ID technology integrated ... Department of Energy,s Oak Ridge National Laboratory (ORNL) ... EyeLock,s iris identity authentication technology is being used to validate ...
(Date:1/22/2015)... Washington , January 20, 2015 Investorideas.com, ... tech stocks, releases video from the CES 2015 (Consumer Electronics ... Apollo Robbins . Apollo shows how easily ... smart wallet, a product of NXT-ID, Inc. (NASDAQ: ...
(Date:1/22/2015)... NEW YORK , Jan. 22, 2015   EyeLock, Inc. ... announced it has appointed Steve Gerber to the ... Gerber will be responsible for leading development of mobile platforms ... 25 years of success and innovation in the semiconductor industry ...
Breaking Biology News(10 mins):EyeLock Debuts First Iris Authentication Technology Embedded in 3D Printed Automobile 2EyeLock Debuts First Iris Authentication Technology Embedded in 3D Printed Automobile 3Apollo Robbins Talks about the Illusion of Personal Safety and How Easily Your Wallet is Stolen; If a Wocket Wallet is Stolen the Thief Can't do Anything With it! 2Apollo Robbins Talks about the Illusion of Personal Safety and How Easily Your Wallet is Stolen; If a Wocket Wallet is Stolen the Thief Can't do Anything With it! 3EyeLock Names Steve Gerber as Senior Vice President of Mobile and Wearables 2
... hosts a panel discussion and open public forum about ... for Biosecurity (NSABB), which advises the U.S. Department of ... journals that they redact key information from unpublished manuscripts ... both good and bad purposes. The research in ...
... 10, 2012  Trovagene, Inc. (Pink Sheets: TROV.PK), a ... Stephen Zaniboni has been named Chief Financial Officer. ... more than $500 million through venture financing and ... of healthcare software solutions company Awarepoint and XIFIN ...
... today that it will receive a tuberculosis (TB) biomarkers ... Challenges in Global Health program, an initiative that seeks ... can radically improve health in the developing world. Urs ... SomaLogic, will pursue an innovative research project to identify ...
Cached Biology News:Georgetown hosts forum to discuss government request of journals to redact scientific data 2Stephen Zaniboni Joins Trovagene, Inc. as Chief Financial Officer 2Stephen Zaniboni Joins Trovagene, Inc. as Chief Financial Officer 3SomaLogic Inc. receives Grand Challenges tuberculosis biomarkers grant 2
(Date:2/27/2015)...  Pharmacyclics, Inc. (NASDAQ: PCYC ) ... newly developed Bruton,s tyrosine kinase (BTK) inhibitor for ... results of these preclinical evaluations have been communicated ... feedback received from the Agency is supportive of ... preclinical work is required to begin a Phase ...
(Date:2/27/2015)... The fully automated supercritical fluidic chromatography-based ... analyze up to 48 samples utilizing automatic extraction ... targets by mass spectrometry. , The Nexera ... requirements of a wide range of applications, including ... search for disease biomarkers, additives in forming polymers, ...
(Date:2/27/2015)... Cytokinetics, Incorporated (Nasdaq: CYTK) announced today ... patients and health care advocates in the United States ... Rare Disease Day is dedicated to elevating public ... special challenges faced by patients with rare diseases and ... to stand alongside patients and caregivers representing the rare ...
(Date:2/26/2015)... WOODBRIDGE, N.J. , Feb. 26, 2015 ... and its affiliated companies, Wilentz, Goldman & ... a trade secrets lawsuit against Genewiz Inc. in excess ... obtained and utilized GenScript,s trade secrets, and that it ... court entered an order denying motions for judgment notwithstanding ...
Breaking Biology Technology:Pharmacyclics Provides Clinical Update on BTK Inhibitor for Autoimmune Diseases 2Pharmacyclics Provides Clinical Update on BTK Inhibitor for Autoimmune Diseases 3Shimadzu Corporation Launches Nexera UC - The World’s Foremost Unified Chromatography System 2Shimadzu Corporation Launches Nexera UC - The World’s Foremost Unified Chromatography System 3Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 2Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 3Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 4Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 5Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 6Wilentz Client GenScript Awarded $10 Million in Trade Secrets Case Against Genewiz 2Wilentz Client GenScript Awarded $10 Million in Trade Secrets Case Against Genewiz 3
... KENILWORTH, N.J., Oct. 11 Schering-Plough,Corporation (NYSE: ... approval from,the European Commission for its planned acquisition ... announced March 12. Organon BioSciences is comprised ... the animal health business. It also,includes Nobilon, the ...
... Calif., Oct. 11 AMDL, Inc. (Amex:,ADL), ... Shenzhen,Jiangxi and Jilin, China, through its wholly ... international biopharma company that,engages in the development, ... products. AMDL announced today that JPI has,signed ...
... vascular tissue processing revenues in the third, quarter of 2007 increased ... ... ATLANTA, Oct. 11 CryoLife, Inc. (NYSE: CRY ),a ... preservation services revenues for the third quarter,of 2007 were approximately $21.9 ...
Cached Biology Technology:Schering-Plough Receives Approval from European Commission for Planned Acquisition of Organon BioSciences N.V. 2AMDL Expands Drug Distribution in China With Additional Agreement, Valued at $2.3 Million Annually 2CryoLife Announces Preliminary Third Quarter 2007 Revenues of Approximately $21.9 Million 2CryoLife Announces Preliminary Third Quarter 2007 Revenues of Approximately $21.9 Million 3CryoLife Announces Preliminary Third Quarter 2007 Revenues of Approximately $21.9 Million 4CryoLife Announces Preliminary Third Quarter 2007 Revenues of Approximately $21.9 Million 5
Rabbit polyclonal to MAL ( Abpromise for all tested applications). entrezGeneID: 4118 SwissProtID: P21145...
Anti-ADAM-12 (Meltrin Alpha); amino terminal region; rabbit host...
Rabbit polyclonal to FLIP ( Abpromise for all tested applications). entrezGeneID: 8837 SwissProtID: O15519...
Mouse monoclonal [3G8] to MDMA ( Abpromise for all tested applications)....
Biology Products: